Company News: Page (1) of 1 - 10/06/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Capricor Therapeutics Reports Intravenous Administration of CAP-1002 Shown to be Effective in Preclinical Models of Duchenne Muscular Dystrophy

Data Lay Groundwork for HOPE-2 Clinical Trial of Company's Lead Investigational Product (October 06, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Pro AV,Management,Presentors,Business,Business Issues,Presentation,People,Events, Inc.,Medicine,Surgery,Medication,Science,Lifestyle,Communications Technology,Medical,Business,Teens,Other,Men,

[ServletException in:/common/ads/links.jsp] Unable to load class for JSP'

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved